
Cecilia M. Jaisle
Examiner (ID: 4742)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624 |
| Total Applications | 688 |
| Issued Applications | 442 |
| Pending Applications | 1 |
| Abandoned Applications | 246 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8928501
[patent_doc_number] => 20130184261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'PYRIDAZINONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/785580
[patent_app_country] => US
[patent_app_date] => 2013-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44522
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13785580
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/785580 | Pyridazinone derivatives | Mar 4, 2013 | Issued |
Array
(
[id] => 8940505
[patent_doc_number] => 20130190302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'MODULATORS OF AMYLOID BETA'
[patent_app_type] => utility
[patent_app_number] => 13/749865
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63405
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13749865
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/749865 | Modulators of amyloid beta | Jan 24, 2013 | Issued |
Array
(
[id] => 8854213
[patent_doc_number] => 20130143888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'PHENOXYMETHYL HETEROCYCLIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/722595
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24887
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722595
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/722595 | Phenoxymethyl heterocyclic compounds | Dec 19, 2012 | Issued |
Array
(
[id] => 9817992
[patent_doc_number] => 08927778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Modular synthesis of graphene nanoribbons and graphene substructures from oligo-alkynes'
[patent_app_type] => utility
[patent_app_number] => 13/658886
[patent_app_country] => US
[patent_app_date] => 2012-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 14451
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13658886
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/658886 | Modular synthesis of graphene nanoribbons and graphene substructures from oligo-alkynes | Oct 23, 2012 | Issued |
Array
(
[id] => 8490101
[patent_doc_number] => 20120289507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'ORGANIC COMPOUNDS AS SMO INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/553870
[patent_app_country] => US
[patent_app_date] => 2012-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43462
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553870
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/553870 | Pyridazinyl derivatives as smo inhibitors | Jul 19, 2012 | Issued |
Array
(
[id] => 8842065
[patent_doc_number] => 20130137693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'LISOFYLLINE ANALOGS AND METHODS FOR USE'
[patent_app_type] => utility
[patent_app_number] => 13/477613
[patent_app_country] => US
[patent_app_date] => 2012-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10019
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477613
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/477613 | Lisofylline analogs and methods for use | May 21, 2012 | Issued |
Array
(
[id] => 8371212
[patent_doc_number] => 20120220599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/462187
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7647
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462187
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/462187 | Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists | May 1, 2012 | Issued |
Array
(
[id] => 9345074
[patent_doc_number] => 08664222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-04
[patent_title] => 'Specific salt, anhydrous and crystalline form of a dihydropteridione derivative'
[patent_app_type] => utility
[patent_app_number] => 13/457991
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8728
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13457991
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/457991 | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative | Apr 26, 2012 | Issued |
Array
(
[id] => 9299860
[patent_doc_number] => 08648088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-11
[patent_title] => 'Ethynyl nitrogen containing heteroaryl pyrazolidin-3-one derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/454167
[patent_app_country] => US
[patent_app_date] => 2012-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8665
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454167
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/454167 | Ethynyl nitrogen containing heteroaryl pyrazolidin-3-one derivatives | Apr 23, 2012 | Issued |
Array
(
[id] => 8347881
[patent_doc_number] => 20120208805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS MEDICAMENTS'
[patent_app_type] => utility
[patent_app_number] => 13/452146
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38798
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13452146
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/452146 | Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments | Apr 19, 2012 | Issued |
Array
(
[id] => 8336311
[patent_doc_number] => 20120202999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'MAPK/ERK KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/450064
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 51829
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450064
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450064 | MAPK/ERK kinase inhibitors | Apr 17, 2012 | Issued |
Array
(
[id] => 8417641
[patent_doc_number] => 20120245141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'ACTIVATORS OF HUMAN PYRUVATE KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/433656
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 34572
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13433656
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/433656 | Activators of human pyruvate kinase | Mar 28, 2012 | Issued |
Array
(
[id] => 8324341
[patent_doc_number] => 20120196750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'PYRIDAZINONE COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/426894
[patent_app_country] => US
[patent_app_date] => 2012-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20030
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13426894
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/426894 | Pyridazinone compound and use thereof | Mar 21, 2012 | Issued |
Array
(
[id] => 9216355
[patent_doc_number] => 08629155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-14
[patent_title] => 'Aspartyl protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/421396
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14663
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13421396
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/421396 | Aspartyl protease inhibitors | Mar 14, 2012 | Issued |
Array
(
[id] => 9113314
[patent_doc_number] => 08569488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Crystalline pyridazine compound'
[patent_app_type] => utility
[patent_app_number] => 13/336512
[patent_app_country] => US
[patent_app_date] => 2011-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11720
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13336512
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/336512 | Crystalline pyridazine compound | Dec 22, 2011 | Issued |
Array
(
[id] => 9496764
[patent_doc_number] => 08735581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Organometallic complex, light-emitting element, light-emitting device, and electronic device including the organometallic complex'
[patent_app_type] => utility
[patent_app_number] => 13/333218
[patent_app_country] => US
[patent_app_date] => 2011-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 18423
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333218
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/333218 | Organometallic complex, light-emitting element, light-emitting device, and electronic device including the organometallic complex | Dec 20, 2011 | Issued |
Array
(
[id] => 9232872
[patent_doc_number] => 08598176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Pyridazine compound and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/324718
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21587
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13324718
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/324718 | Pyridazine compound and use thereof | Dec 12, 2011 | Issued |
Array
(
[id] => 8240966
[patent_doc_number] => 20120149700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => '2-CYANOPHENYL FUSED HETEROCYCLIC COMPOUNDS, AND COMPOSTIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/323748
[patent_app_country] => US
[patent_app_date] => 2011-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49082
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13323748
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/323748 | 2-CYANOPHENYL FUSED HETEROCYCLIC COMPOUNDS, AND COMPOSTIONS AND USES THEREOF | Dec 11, 2011 | Abandoned |
Array
(
[id] => 8253152
[patent_doc_number] => 20120157476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'OXIME COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/314224
[patent_app_country] => US
[patent_app_date] => 2011-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19176
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157476.pdf
[firstpage_image] =>[orig_patent_app_number] => 13314224
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/314224 | Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents | Dec 7, 2011 | Issued |
Array
(
[id] => 8228500
[patent_doc_number] => 20120142708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'SUBSTITUTED PYRIDINE UREA COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/312768
[patent_app_country] => US
[patent_app_date] => 2011-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16431
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13312768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/312768 | Substituted pyridine urea compounds | Dec 5, 2011 | Issued |